Magnesium-zinc-strontium alloys for medical implants and devices

US10246763B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10246763-B2
Application numberUS-201313975881-A
CountryUS
Kind codeB2
Filing dateAug 26, 2013
Priority dateAug 24, 2012
Publication dateApr 2, 2019
Grant dateApr 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical implant and/or device, which includes a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed. The implant and/or device can include a biodegradable and cytocompatible magnesium-zinc-strontium (Mg—Zn—Sr) alloy having a weight percent composition of Zn and Sr as follows: 0.01≤Zn≤6 wt %, 0.01≤Sr≤3 wt %. A method for manufacturing an implant in the form of a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed, which includes melting the biodegradable and cytocompatible magnesium-zinc-strontium alloy in an inert environment and molding the biodegradable magnesium-zinc-strontium alloy in a semi-solid state.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy; and a weight percent of zinc being 4.0 to 6.0, a weight percent of strontium being 0.01 to 0.15, and a balance of the medical implant being magnesium. 2. The medical implant according to claim 1 , wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 3. The medical implant according to claim 2 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 4. The medical implant according to claim 1 , wherein the implant is composed of only the biodegradable magnesium-zinc-strontium alloy. 5. The medical implant according to claim 1 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant. 6. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy, wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of Zn and Sr as follows: 4.0≤Zn≤6.0 wt. %, 0.01≤Sr≤0.15 wt. %, and a balance of the medical implant being magnesium; and wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 7. The medical implant according claim 6 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 8. The medical implant according to claim 6 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant. 9. The medical implant according to claim 6 , wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of 95.85 wt. % Mg, 4 wt. % Zn, and 0.15 wt. % Sr. 10. The medical implant according to claim 6 , wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of 94.5-95.85 wt. % Mg, 4 wt. % Zn, and 0.01-0.15 wt. % Sr. 11. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy, wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent of 91-95.84 wt. % Mg, 4.0-6.0 wt. % Zn, and 0.01-0.015 wt. % Sr. 12. The medical implant according to claim 11 , wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 13. The medical implant according claim 12 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 14. The medical implant according to claim 11 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant or device.

Assignees

Inventors

Classifications

  • with zinc or cadmium as the next major constituent · CPC title

  • Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title

  • Extruding metal; Impact extrusion · CPC title

  • Other specific inorganic materials not covered by A61L27/303 - A61L27/32 · CPC title

  • Metals or alloys · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10246763B2 cover?
A medical implant and/or device, which includes a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed. The implant and/or device can include a biodegradable and cytocompatible magnesium-zinc-strontium (Mg—Zn—Sr) alloy having a weight percent composition of Zn and Sr as follows: 0.01≤Zn≤6 wt %, 0.01≤Sr≤3 wt %. A method for manufacturing an implant in the form of a biodeg…
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C22C23/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).